http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#Head http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#provenance http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#pubinfo http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6018 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.bioontology.org/ontology/MSH/D009132 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.bioontology.org/ontology/MSH/D017667 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_1 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/positiveCorrelation http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases/Type%20II%20diabetes http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.w3.org/2000/01/rdf-schema#label path(SDIS:"Type II diabetes") positiveCorrelation p(HGNC:IL6) http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#provenance http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_4 http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/version 1.4 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_3 http://www.w3.org/ns/prov#value indicating that IL-6 effects on muscle metabolism may be mediated through increased lipid availability. Decreases in fatty acid oxidation and increased fatty acid uptake have been proposed as possible mechanisms of increased lipid accumulation, which causes insulin resistance, with obesity (48) and diabetes. Thus elevated fasting plasma IL-6 concentrations would be detrimental to insulin action. Serum IL-6 levels are elevated with obesity (57) and diabetes (28) and are negatively related with insulin-stimulated glucose disposal during a euglycemic-hyperinsulinemic clamp (57). http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/16020439 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/16020439 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#_3 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI#pubinfo http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://purl.org/dc/terms/created 2014-07-03T14:30:36.849+02:00 http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAeZ6H2kE8txs-LJbFriKNWveDq31jmqDrOlzqYT2NwOI http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234